Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2021

01-11-2021 | Probiotics | Original Article

Polyphosphate, Derived from Lactobacillus brevis, Modulates the Intestinal Microbiome and Attenuates Acute Pancreatitis

Authors: Shuhei Takauji, Hiroaki Konishi, Mikihiro Fujiya, Nobuhiro Ueno, Hiroki Tanaka, Hiroki Sato, Shotaro Isozaki, Shin Kashima, Kentaro Moriichi, Yusuke Mizukami, Toshikatsu Okumura

Published in: Digestive Diseases and Sciences | Issue 11/2021

Login to get access

Abstract

Background

We previously showed that Lactobacillus brevis-derived polyphosphate (poly P) exerts a curative effect on intestinal inflammation. However, whether or not poly P improves the inflammation and injury of distant organs remains unclear.

Aims

We aimed to investigate the change in the intestinal microbiome and to evaluate the protective effect of poly P on injuries in a cerulein-induced acute pancreatitis (AP) mouse.

Methods

Poly P was orally administered to BALB/C mice every day for 24 days, and then mice were intraperitoneally injected with cerulein. Before cerulein injection, stool samples were collected and analyzed by 16S rRNA gene sequencing. Mice were sacrificed at 24 h after the last cerulein injection; subsequently, the serum, pancreas, and colon were collected.

Results

The microbial profile differed markedly between poly P and control group. Notably, the levels of beneficial bacteria, including Alistipes and Candidatus_Saccharimonas, were significantly increased, while those of the virulent bacteria Desulfovibrio were decreased in the poly P group. The elevations of the serum amylase and lipase levels by cerulein treatment were suppressed by the pre-administration of poly P for 24 days, but not for 7 days. The numbers of cells MPO-positive by immunohistology were decreased and the levels of MCP-1 significantly reduced in the AP + Poly P group. An immunofluorescence analysis showed that the ZO-1 and occludin in the colon was strongly augmented in the epithelial cell membrane layer in the AP + Poly P group.

Conclusions

Poly P attenuates AP through both modification of the intestinal microbiome and enhancement of the intestinal barrier integrity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med.. 2018;24:392–400.CrossRef Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R. Current understanding of the human microbiome. Nat Med.. 2018;24:392–400.CrossRef
2.
go back to reference Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology.. 2013;145:946–953.CrossRef Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology.. 2013;145:946–953.CrossRef
3.
go back to reference Chen J, Huang C, Wang J, et al. Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats. PLoS ONE.. 2017;12:e0176583.CrossRef Chen J, Huang C, Wang J, et al. Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats. PLoS ONE.. 2017;12:e0176583.CrossRef
4.
go back to reference Huang C, Chen J, Wang J, et al. Dysbiosis of intestinal microbiota and decreased antimicrobial peptide level in Paneth cells during hypertriglyceridemia-related acute necrotizing pancreatitis in rats. Front Microbiol.. 2017;8:776.CrossRef Huang C, Chen J, Wang J, et al. Dysbiosis of intestinal microbiota and decreased antimicrobial peptide level in Paneth cells during hypertriglyceridemia-related acute necrotizing pancreatitis in rats. Front Microbiol.. 2017;8:776.CrossRef
5.
go back to reference FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001. FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001.
6.
go back to reference Segawa S, Fujiya M, Konishi H, et al. Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS ONE. 2011;6:e23278.CrossRef Segawa S, Fujiya M, Konishi H, et al. Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS ONE. 2011;6:e23278.CrossRef
7.
go back to reference Kornberg A, Rao NN, Ault-Riche D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem.. 1999;68:89–125.CrossRef Kornberg A, Rao NN, Ault-Riche D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem.. 1999;68:89–125.CrossRef
8.
go back to reference Tanaka K, Fujiya M, Konishi H, et al. Probiotic-derived polyphosphate improves the intestinal barrier function through the caveolin-dependent endocytic pathway. Biochem Biophys Res Commun.. 2015;467:541–548.CrossRef Tanaka K, Fujiya M, Konishi H, et al. Probiotic-derived polyphosphate improves the intestinal barrier function through the caveolin-dependent endocytic pathway. Biochem Biophys Res Commun.. 2015;467:541–548.CrossRef
9.
go back to reference Kashima S, Fujiya M, Konishi H, et al. Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis. Transl Res.. 2015;166:163–175.CrossRef Kashima S, Fujiya M, Konishi H, et al. Polyphosphate, an active molecule derived from probiotic Lactobacillus brevis, improves the fibrosis in murine colitis. Transl Res.. 2015;166:163–175.CrossRef
10.
go back to reference Fujiya M, Ueno N, Kashima S, et al. Long-Chain polyphosphate is a potential agent for inducing mucosal healing of the colon in ulcerative Colitis. Clin Pharmacol Ther.. 2020;107:452–461.CrossRef Fujiya M, Ueno N, Kashima S, et al. Long-Chain polyphosphate is a potential agent for inducing mucosal healing of the colon in ulcerative Colitis. Clin Pharmacol Ther.. 2020;107:452–461.CrossRef
11.
go back to reference Algul H, Tando Y, Schneider G, Weidenbach H, Adler G, Schmid RM. Acute experimental pancreatitis and NF-kappaB/Rel activation. Pancreatology.. 2002;2:503–509.CrossRef Algul H, Tando Y, Schneider G, Weidenbach H, Adler G, Schmid RM. Acute experimental pancreatitis and NF-kappaB/Rel activation. Pancreatology.. 2002;2:503–509.CrossRef
12.
go back to reference Zhu Y, He C, Li X, et al. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice. J Gastroenterol.. 2019;54:347–358.CrossRef Zhu Y, He C, Li X, et al. Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice. J Gastroenterol.. 2019;54:347–358.CrossRef
13.
go back to reference Watanabe T, Kudo M, Strober W. Immunopathogenesis of pancreatitis. Mucosal Immunol.. 2017;10:283–298.CrossRef Watanabe T, Kudo M, Strober W. Immunopathogenesis of pancreatitis. Mucosal Immunol.. 2017;10:283–298.CrossRef
14.
go back to reference Maier SK, Scherer S, Loessner MJ. Long-chain polyphosphate causes cell lysis and inhibits Bacillus cereus septum formation, which is dependent on divalent cations Appl Environ Microbiol. 1999;65:3942-3949; Lee RM, Hartman PA, Stahr HM, Olson DG, Williams FD. Antibacterial Mechanism of Long-Chain Polyphosphates in Staphylococcus aureus J Food Prot. 1994;57:289-294. Maier SK, Scherer S, Loessner MJ. Long-chain polyphosphate causes cell lysis and inhibits Bacillus cereus septum formation, which is dependent on divalent cations Appl Environ Microbiol. 1999;65:3942-3949; Lee RM, Hartman PA, Stahr HM, Olson DG, Williams FD. Antibacterial Mechanism of Long-Chain Polyphosphates in Staphylococcus aureus J Food Prot. 1994;57:289-294.
15.
go back to reference Hasebe T, Ueno N, Musch MW, et al. Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K. Pharmacol Res Perspect.. 2016;4:e00215.CrossRef Hasebe T, Ueno N, Musch MW, et al. Daikenchuto (TU-100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K. Pharmacol Res Perspect.. 2016;4:e00215.CrossRef
16.
go back to reference Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods.. 2010;7:335–336.CrossRef Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods.. 2010;7:335–336.CrossRef
17.
go back to reference Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol.. 2011;12:R60.CrossRef Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol.. 2011;12:R60.CrossRef
18.
go back to reference Yang ZW, Meng XX, Xu P. Central role of neutrophil in the pathogenesis of severe acute pancreatitis. J Cell Mol Med.. 2015;19:2513–2520.CrossRef Yang ZW, Meng XX, Xu P. Central role of neutrophil in the pathogenesis of severe acute pancreatitis. J Cell Mol Med.. 2015;19:2513–2520.CrossRef
19.
go back to reference Rychter JW, van Minnen LP, Verheem A, et al. Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis. Surgery.. 2009;145:157–167.CrossRef Rychter JW, van Minnen LP, Verheem A, et al. Pretreatment but not treatment with probiotics abolishes mouse intestinal barrier dysfunction in acute pancreatitis. Surgery.. 2009;145:157–167.CrossRef
20.
go back to reference van Minnen LP, Timmerman HM, Lutgendorff F, et al. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery.. 2007;141:470–480.CrossRef van Minnen LP, Timmerman HM, Lutgendorff F, et al. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. Surgery.. 2007;141:470–480.CrossRef
21.
go back to reference Muftuoglu MAT, Isikgor S, Tosun S, Saglam A. Effects of probiotics on the severity of experimental acute pancreatitis. Eur J Clin Nutrit.. 2005;60:464–468.CrossRef Muftuoglu MAT, Isikgor S, Tosun S, Saglam A. Effects of probiotics on the severity of experimental acute pancreatitis. Eur J Clin Nutrit.. 2005;60:464–468.CrossRef
22.
go back to reference Jin D-Y, Lutgendorff F, Nijmeijer RMet al.. Probiotics Prevent Intestinal Barrier Dysfunction in Acute Pancreatitis in Rats via Induction of Ileal Mucosal Glutathione Biosynthesis PLoS ONE. 2009;4. Jin D-Y, Lutgendorff F, Nijmeijer RMet al.. Probiotics Prevent Intestinal Barrier Dysfunction in Acute Pancreatitis in Rats via Induction of Ileal Mucosal Glutathione Biosynthesis PLoS ONE. 2009;4.
23.
go back to reference Jo IJ, Bae GS, Choi SBet al.. Fisetin attenuates cerulein-induced acute pancreatitis through down regulation of JNK and NF-kappaB signaling pathways Eur J Pharmacol. 2014;737:149-158; Ren Z, Li H, Zhang Met al.. A Novel Derivative of the Natural Product Danshensu Suppresses Inflammatory Responses to Alleviate Caerulein-Induced Acute Pancreatitis Front Immunol. 2018;9:2513. Jo IJ, Bae GS, Choi SBet al.. Fisetin attenuates cerulein-induced acute pancreatitis through down regulation of JNK and NF-kappaB signaling pathways Eur J Pharmacol. 2014;737:149-158; Ren Z, Li H, Zhang Met al.. A Novel Derivative of the Natural Product Danshensu Suppresses Inflammatory Responses to Alleviate Caerulein-Induced Acute Pancreatitis Front Immunol. 2018;9:2513.
24.
go back to reference Zhang H, Yang W, Li Y, et al. Astaxanthin ameliorates cerulein-induced acute pancreatitis in mice. Int Immunopharmacol.. 2018;56:18–28.CrossRef Zhang H, Yang W, Li Y, et al. Astaxanthin ameliorates cerulein-induced acute pancreatitis in mice. Int Immunopharmacol.. 2018;56:18–28.CrossRef
25.
go back to reference Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc National Acad Sci United States America.. 2007;104:13780–13785.CrossRef Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc National Acad Sci United States America.. 2007;104:13780–13785.CrossRef
26.
go back to reference Wu M, Li P, An Y, et al. Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol Res.. 2019;150:104489.CrossRef Wu M, Li P, An Y, et al. Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol Res.. 2019;150:104489.CrossRef
27.
go back to reference Huang Y, Li M, Zhou L, et al. Effects of Qingluo Tongbi decoction on gut flora of rats with adjuvant-induced arthritis and the underlying mechanism evid based complement. Alternat Med.. 2019;2019:6308021. Huang Y, Li M, Zhou L, et al. Effects of Qingluo Tongbi decoction on gut flora of rats with adjuvant-induced arthritis and the underlying mechanism evid based complement. Alternat Med.. 2019;2019:6308021.
28.
go back to reference Rowan F, Docherty NG, Murphy M, Murphy B, Calvin Coffey J, O’Connell PR. Desulfovibrio bacterial species are increased in ulcerative colitis. Diseases Colon Rectum.. 2010;53:1530–1536.CrossRef Rowan F, Docherty NG, Murphy M, Murphy B, Calvin Coffey J, O’Connell PR. Desulfovibrio bacterial species are increased in ulcerative colitis. Diseases Colon Rectum.. 2010;53:1530–1536.CrossRef
29.
go back to reference Sawin EA, De Wolfe TJ, Aktas B, et al. Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. Am J Physiol Gastrointest Liver Physiol.. 2015;309:G590–G601.CrossRef Sawin EA, De Wolfe TJ, Aktas B, et al. Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. Am J Physiol Gastrointest Liver Physiol.. 2015;309:G590–G601.CrossRef
31.
go back to reference Hagiya H, Kimura K, Nishi I, et al. Desulfovibrio desulfuricans bacteremia: A case report and literature review. Anaerobe.. 2018;49:112–115.CrossRef Hagiya H, Kimura K, Nishi I, et al. Desulfovibrio desulfuricans bacteremia: A case report and literature review. Anaerobe.. 2018;49:112–115.CrossRef
32.
go back to reference Zhang J, Yu WQ, Wei T, et al. Effects of short-peptide-based enteral nutrition on the intestinal microcirculation and mucosal barrier in mice with severe acute pancreatitis. Mol Nutr Food Res.. 2020;64:e1901191.CrossRef Zhang J, Yu WQ, Wei T, et al. Effects of short-peptide-based enteral nutrition on the intestinal microcirculation and mucosal barrier in mice with severe acute pancreatitis. Mol Nutr Food Res.. 2020;64:e1901191.CrossRef
33.
go back to reference Jia L, Chen H, Yang J, et al. Combinatory antibiotic treatment protects against experimental acute pancreatitis by suppressing gut bacterial translocation to pancreas and inhibiting NLRP3 inflammasome pathway. Innate Immun.. 2020;26:48–61.CrossRef Jia L, Chen H, Yang J, et al. Combinatory antibiotic treatment protects against experimental acute pancreatitis by suppressing gut bacterial translocation to pancreas and inhibiting NLRP3 inflammasome pathway. Innate Immun.. 2020;26:48–61.CrossRef
34.
go back to reference Ryan CM, Schmidt J, Lewandrowski K, et al. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats. Gastroenterology.. 1993;104:890–895.CrossRef Ryan CM, Schmidt J, Lewandrowski K, et al. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats. Gastroenterology.. 1993;104:890–895.CrossRef
35.
go back to reference Tsuji Y, Watanabe T, Kudo M, Arai H, Strober W, Chiba T. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. Immunity.. 2012;37:326–338.CrossRef Tsuji Y, Watanabe T, Kudo M, Arai H, Strober W, Chiba T. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. Immunity.. 2012;37:326–338.CrossRef
36.
go back to reference Rau B, Baumgart K, Kruger CM, Schilling M, Beger HG. CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med.. 2003;29:622–629.CrossRef Rau B, Baumgart K, Kruger CM, Schilling M, Beger HG. CC-chemokine activation in acute pancreatitis: enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications. Intensive Care Med.. 2003;29:622–629.CrossRef
37.
go back to reference Ishibashi T, Zhao H, Kawabe K, et al. Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats. J Gastroenterol.. 2008;43:79–85.CrossRef Ishibashi T, Zhao H, Kawabe K, et al. Blocking of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the severity of acute pancreatitis in rats. J Gastroenterol.. 2008;43:79–85.CrossRef
38.
go back to reference Bhatia M, Ramnath RD, Chevali L, Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol.. 2005;288:G1259–G1265.CrossRef Bhatia M, Ramnath RD, Chevali L, Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol.. 2005;288:G1259–G1265.CrossRef
39.
go back to reference Frossard JL, Lenglet S, Montecucco F, et al. Role of CCL-2, CCR-2 and CCR-4 in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury. J Clin Pathol.. 2011;64:387–393.CrossRef Frossard JL, Lenglet S, Montecucco F, et al. Role of CCL-2, CCR-2 and CCR-4 in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury. J Clin Pathol.. 2011;64:387–393.CrossRef
40.
go back to reference Bedrosian AS, Nguyen AH, Hackman M, et al. Dendritic cells promote pancreatic viability in mice with acute pancreatitis. Gastroenterology.. 2011;141:e1911–e1914.CrossRef Bedrosian AS, Nguyen AH, Hackman M, et al. Dendritic cells promote pancreatic viability in mice with acute pancreatitis. Gastroenterology.. 2011;141:e1911–e1914.CrossRef
41.
go back to reference Shrivastava P, Bhatia M. Essential role of monocytes and macrophages in the progression of acute pancreatitis. World J Gastroenterol.. 2010;16:3995–4002.CrossRef Shrivastava P, Bhatia M. Essential role of monocytes and macrophages in the progression of acute pancreatitis. World J Gastroenterol.. 2010;16:3995–4002.CrossRef
42.
go back to reference Tsai MJ, Chen C, Chen SH, Huang YT, Chiu TH. Pomalidomide suppresses cerulein-induced acute pancreatitis in mice. J Gastroenterol.. 2011;46:822–833.CrossRef Tsai MJ, Chen C, Chen SH, Huang YT, Chiu TH. Pomalidomide suppresses cerulein-induced acute pancreatitis in mice. J Gastroenterol.. 2011;46:822–833.CrossRef
43.
go back to reference Ding SP, Li JC, Jin C. A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol.. 2003;9:584–589.CrossRef Ding SP, Li JC, Jin C. A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol.. 2003;9:584–589.CrossRef
Metadata
Title
Polyphosphate, Derived from Lactobacillus brevis, Modulates the Intestinal Microbiome and Attenuates Acute Pancreatitis
Authors
Shuhei Takauji
Hiroaki Konishi
Mikihiro Fujiya
Nobuhiro Ueno
Hiroki Tanaka
Hiroki Sato
Shotaro Isozaki
Shin Kashima
Kentaro Moriichi
Yusuke Mizukami
Toshikatsu Okumura
Publication date
01-11-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06747-9

Other articles of this Issue 11/2021

Digestive Diseases and Sciences 11/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine